Racial Disparities in Acromegaly and Cushing's Disease: A Referral Center Study in 241 Patients

被引:11
作者
Ioachimescu, Adriana G. [1 ,2 ]
Goswami, Neevedita [2 ]
Handa, Talin [3 ]
Pappy, Adlai [4 ]
Veledar, Emir [5 ]
Oyesiku, Nelson M. [1 ,2 ]
机构
[1] Emory Sch Med, Dept Med Endocrinol, Atlanta, GA 30322 USA
[2] Emory Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA
[3] UCF Coll Med, Orlando, FL 32827 USA
[4] Brigham & Womens Hosp, Dept Anesthesiol & Pain Med, 75 Francis St, Boston, MA 02115 USA
[5] Baptist Hlth South Florida, Coral Gables, FL 33146 USA
关键词
acromegaly; Cushing's disease; race; racial differences; transsphenoidal surgery; remission; PITUITARY-ADENOMAS; UNITED-STATES; SURGERY; EPIDEMIOLOGY; PREVALENCE; PREDICTORS;
D O I
10.1210/jendso/bvab176
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Acromegaly (ACM) and Cushing's disease (CD) are caused by functioning pituitary adenomas secreting growth hormone and ACTH respectively. Objective: To determine the impact of race on presentation and postoperative outcomes in adults with ACM and CD, which has not yet been evaluated. Methods. This is a retrospective study of consecutive patients operated at a large-volume pituitary center. We evaluated (1) racial distribution of patients residing in the metropolitan area (Metro, N = 124) vs 2010 US census data, and(2) presentation and postoperative outcomes in Black vs White for patients from the entire catchment area (N = 241). Results. For Metro area (32.4% Black population), Black patients represented 16.75% ACM (P =.006) and 29.2% CD (P = .56). Among the total 112 patients with ACM, presentations with headaches or incidentaloma were more common in Black patients (76.9% vs 31% White, P = .01). Black patients had a higher prevalence of diabetes (54% vs 16% White, P = .005), significantly lower interferon insulin-like growth factor (IGF)-1 deviation from normal (P = .03) and borderline lower median growth hormone levels (P = .09). Mean tumor diameter and proportion of tumors with cavernous sinus invasion were similar. Three-month biochemical remission (46% Black, 55% White, P = .76) and long-term IGF-1 control by multimodality therapy (92.3% Black, 80.5% White, P = .45) were similar. Among the total 129 patients with CD, Black patients had more hypopituitarism (69% vs 45% White, P = .04) and macroadenomas (33% vs 15% White, P = .05). At 3 months, remission rate was borderline higher in White (92% vs 78% Black, P = 0.08), which was attributed to macroadenomas by logistic regression. Conclusion. We identified disparities regarding racial distribution, and clinical and biochemical characteristics in ACM, suggesting late or missed diagnosis in Black patients. Large nationwide studies are necessary to confirm our findings.
引用
收藏
页数:9
相关论文
共 33 条
[1]   PREDICTORS OF BIOCHEMICAL REMISSION AND RECURRENCE AFTER SURGICAL AND RADIATION TREATMENTS OF CUSHING DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS [J].
Abu Dabrh, Abd Moain ;
Ospina, Naykky M. Singh ;
Al Nofal, Alaa ;
Farah, Wigdan H. ;
Barrionuevo, Patricia ;
Sarigianni, Maria ;
Mohabbat, Arya B. ;
Benkhadra, Khalid ;
Leon, Barbara G. Carranza ;
Gionfriddo, Michael R. ;
Wang, Zhen ;
Mohammed, Khaled ;
Ahmed, Ahmed T. ;
Elraiyah, Tarig A. ;
Haydour, Qusay ;
Alahdab, Fares ;
Prokop, Larry J. ;
Murad, Mohammad Hassan .
ENDOCRINE PRACTICE, 2016, 22 (04) :466-475
[2]   Epidemiology and etiopathogenesis of pituitary adenomas [J].
Aflorei, Elena D. ;
Korbonits, Marta .
JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (03) :379-394
[3]   Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review [J].
Agrawal, Nidhi ;
Ioachimescu, Adriana G. .
PITUITARY, 2020, 23 (05) :582-594
[4]  
Ahmed S, 1999, CLIN ENDOCRINOL, V50, P561
[5]   Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: Mortality, morbidity, and the effects of hospital and surgeon volume [J].
Barker, FG ;
Klibanski, A ;
Swearingen, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4709-4719
[6]   Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement [J].
Casanueva, Felipe F. ;
Barkan, Ariel L. ;
Buchfelder, Michael ;
Klibanski, Anne ;
Laws, Edward R. ;
Loeffler, Jay S. ;
Melmed, Shlomo ;
Mortini, Pietro ;
Wass, John ;
Giustina, Andrea .
PITUITARY, 2017, 20 (05) :489-498
[7]   High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium [J].
Daly, Adrian F. ;
Rixhon, Martine ;
Adam, Christelle ;
Dempegioti, Anastasia ;
Tichomirowa, Maria A. ;
Beckers, Albert .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12) :4769-4775
[8]   The Epidemiology of Pituitary Adenomas [J].
Daly, Adrian F. ;
Beckers, Albert .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2020, 49 (03) :347-+
[9]   Socioeconomic Predictors of Pituitary Surgery [J].
Deb, Sayantan ;
Vyas, Daivik B. ;
Pendharkar, Arjun, V ;
Rezaii, Paymon G. ;
Schoen, Matthew K. ;
Desai, Kaniksha ;
Gephart, Melanie H. ;
Desai, Atman .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)
[10]   Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina [J].
Fainstein Day, Patricia ;
Graciela Loto, Monica ;
Glerean, Mariela ;
Russo Picasso, Maria Fabiana ;
Lovazzano, Soledad ;
Hernan Giunta, Diego .
ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (06) :554-561